Literature DB >> 324688

Monitoring gold plasma levels in rheumatoid arthritis.

A Lorber.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 324688     DOI: 10.2165/00003088-197702020-00004

Source DB:  PubMed          Journal:  Clin Pharmacokinet        ISSN: 0312-5963            Impact factor:   6.447


× No keyword cloud information.
  33 in total

1.  DETERMINATION OF GOLD IN SERUM AND URINE BY NEUTRON ACTIVATION ANALYSIS.

Authors:  S SOLVSTEN
Journal:  Scand J Clin Lab Invest       Date:  1964       Impact factor: 1.713

2.  METABOLISM, TOXICITY AND MANNER OF ACTION OF GOLD COMPOUNDS USED IN THE TREATMENT OF ARTHRITIS. I. HUMAN PLASMA AND SYNOVIAL FLUID CONCENTRATION AND URINARY EXCRETION OF GOLD DURING AND FOLLOWING TREATMENT WITH GOLD SODIUM THIOMALATE, GOLD SODIUM THIOSULFATE, AND COLLOIDAL GOLD SULFIDE.

Authors:  R H Freyberg; W D Block; S Levey
Journal:  J Clin Invest       Date:  1941-07       Impact factor: 14.808

3.  Gold Therapy in Rheumatoid Arthritis: Final Report of a Multicentre Controlled Trial.

Authors: 
Journal:  Ann Rheum Dis       Date:  1961-12       Impact factor: 19.103

4.  Studies with radioactive gold.

Authors:  J S LAWRENCE
Journal:  Ann Rheum Dis       Date:  1961-12       Impact factor: 19.103

5.  Tissue gold levels after chrysotherapy.

Authors:  R Grahame; R Billings; M Laurence; V Marks; P J Wood
Journal:  Ann Rheum Dis       Date:  1974-11       Impact factor: 19.103

6.  Monitoring serum gold values to improve chrysotherapy in rheumatoid arthritis.

Authors:  A Lorber; C J Atkins; C C Chang; Y B Lee; J Starrs; R A Bovy
Journal:  Ann Rheum Dis       Date:  1973-03       Impact factor: 19.103

7.  Letter: Metabolism of gold during lactation.

Authors:  S P Blau
Journal:  Arthritis Rheum       Date:  1973 Nov-Dec

8.  Gold determination in biological fluids by atomic absorption spectrophotometry: application to chrysotherapy in rheumatoid arthritis patients.

Authors:  A Lorber; R L Cohen; C C Chang; H E Anderson
Journal:  Arthritis Rheum       Date:  1968-04

9.  Electron-dense deposits following injection of gold sodium thiomalate and thiomalic acid.

Authors:  W L Norton; D C Lewis; M Ziff
Journal:  Arthritis Rheum       Date:  1968-06

10.  Gold excretion correlated with clinical course during chrysotherapy in rheumatoid arthritis.

Authors:  N L Gottlieb; P M Smith; E M Smith
Journal:  Arthritis Rheum       Date:  1972 Nov-Dec
View more
  9 in total

Review 1.  Guide to drug dosage in renal failure.

Authors:  W M Bennett
Journal:  Clin Pharmacokinet       Date:  1988-11       Impact factor: 6.447

2.  Serum gold concentrations during treatment with auranofin.

Authors:  P L Van Riel; F W Gribnau; L B Van de Putte; C W Arts; A Van Aernsbergen
Journal:  Clin Rheumatol       Date:  1987-03       Impact factor: 2.980

3.  A three year comparative study of auranofin and gold sodium thiomalate in rheumatoid arthritis.

Authors:  R Rau; M Schattenkirchner; H Muller-Fassbender; B Kaik; H Zeidler; B Missler
Journal:  Clin Rheumatol       Date:  1990-12       Impact factor: 2.980

Review 4.  Have traditional DMARDs had their day? Effectiveness of parenteral gold compared to biologic agents.

Authors:  Rolf Rau
Journal:  Clin Rheumatol       Date:  2004-07-24       Impact factor: 2.980

5.  Effect of two gold compounds on lysosomes.

Authors:  P M Graabaek; S M Pedersen
Journal:  Ann Rheum Dis       Date:  1988-06       Impact factor: 19.103

6.  [Clinical trial in couples of effectiveness and side-effects of gold and D-penicillamine in long term treatment of rheumatoid arthritis (author's transl)].

Authors:  J D Herrlinger; W Kriegel; J Drews; F Hölscher; R Schmidt
Journal:  Klin Wochenschr       Date:  1980-08-15

7.  Pharmacokinetics of gold sodium thiomalate in rabbits.

Authors:  S Melethil; D Schoepp
Journal:  Pharm Res       Date:  1987-08       Impact factor: 4.200

Review 8.  Clinical pharmacokinetics of slow-acting antirheumatic drugs.

Authors:  S E Tett
Journal:  Clin Pharmacokinet       Date:  1993-11       Impact factor: 6.447

9.  Fate of the gold and the thiomalate part after intramuscular administration of aurothiomalate to mice.

Authors:  E Jellum; E Munthe; G Guldal; J Aaseth
Journal:  Ann Rheum Dis       Date:  1980-04       Impact factor: 19.103

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.